Tenaya Therapeutics Inc (NASDAQ:TNYA) concluded the trading at $0.52 on Thursday, April 03 with a fall of -8.11% from its closing price on previous day.
Taking a look at stock we notice that its last check on previous day was $0.57 and 5Y monthly beta was reading 2.987 with its price kept floating in the range of $0.5016 and $0.5435 on the day. Considering stock’s 52-week price range provides that TNYA hit a high price of $5.10 and saw its price falling to a low level of $0.39 during that period. Over a period of past 1-month, stock came adding 14.29% in its value.
In contrast, when we review TNYA stock’s current outlook then short term indicators are assigning it an average of 100% Sell, while medium term indicators are categorizing the stock at an average of 100% Sell. Long term indicators are suggesting an average of 100% Sell for it.
According to ratings assigned by 3 analysts at the scale of 1 to 5 with 1.00 representing a strong buy and 5.00 suggesting a strong sell; 0 of them are recommending Tenaya Therapeutics Inc (TNYA) as a Hold, while 3 are in view that stock is a Buy. Recommendation by 0 analysts for the stock is an Underweight while number of those analysts who rated the stock as an Overweight is 0, whereas 0 of them are considering the stock as a Sell. When taken as whole, stock gets a rating of Overweight and that encourages the investors to exploit the opportunity and build their stake up in the company.
Digging deeper we become aware of the PEG ratio of the TNYA stock which is currently positioned at 0. It further provides that stock’s current price level is -16.14% away from its 20-day simple moving average and is -38.42% off its SMA50. Its relative strength index (RSI) for 14-periods is oscillating at 35.26 while volatility remained at 10.51% over the past week which changes to 12.31% when measuring it over the past month. Beta is valued at 2.99, while measure of average true range or ATR is currently at 0.08.
Having a second look at Tenaya Therapeutics Inc (NASDAQ:TNYA) provides that stock’s average daily trading volume for 3 months was 3.36 million, while it jumped to 2951150 when we calculate an average volume for past 10 days. Number of outstanding shares of the stock stood at 162.58 million.
The percentage of outstanding shares held by the insiders is 17.52% while it is 20.39% for the institutional holders. The figures also indicate that as of 2025-03-14, number of stock’s short shares was 11.22 million which implies a short ratio of 1.96. This shows down a 809.00 of Short Interest in company’s outstanding shares on the day. In March the standing of shares short improved as it was 13.37 million in the previous month. Subtraction of -63.64% by stock’s current price to its year-to-date value in last trading session is likely to be increasing investors’ interest in the stock as it is hinting an extended uptrend.